Share Price | BioRestorative Therapies, Inc. Stock Analysis & Recommendation

Q: How big is BioRestorative Therapies, Inc.?

Market Cap: As of Jun 18, BioRestorative Therapies, Inc. has a market capitalization of 12.91 million, categorizing it as a Micro Cap company.Recent Quarterly Performance: For the latest four quarters, the company reported net sales of 0.39 million and a net profit of -12.10 million.Balance Sheet Snapshot: As of Dec 24, the company's shareholder's funds amounted to 8.53 million, while total assets were reported at 12.28 million.

Q: What does BioRestorative Therapies, Inc. do?

Overview: BioRestorative Therapies, Inc. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.Financial Snapshot: Most recent Net Sales: 0 Million (Quarterly Results - Mar 2025) Most recent Net Profit: -5 Million (Quarterly Results - Mar 2025) Market-cap: USD 12.91 Million (Micro Cap)Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -1.48 Return on Equity: -190.35% Price to Book: 2.10Contact Details: Details: No Company Details Available Registrar Address: Not available.

Q: Is BioRestorative Therapies, Inc. technically bullish or bearish?

As of 4 September 2025, the technical trend for BioRestorative Therapies, Inc. has changed from sideways to mildly bearish. The current technical stance is bearish, with key indicators driving this sentiment including daily moving averages and weekly KST showing bearish tendencies. While the MACD is mildly bullish on both weekly and monthly time frames, the overall bearish signals from Bollinger Bands and OBV contribute to a weaker outlook. In terms of performance, the stock has underperformed the S&P 500 across multiple periods, with a 1-year return of -12.12% compared to the S&P 500's 17.14%.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

42.13 k

Shareholding (Sep 2025)

FII

0.00%

Held by 3 FIIs

DII

97.98%

Held by 2 DIIs

Promoter

0.00%

How big is BioRestorative Therapies, Inc.?

22-Jun-2025

As of Jun 18, BioRestorative Therapies, Inc. has a market capitalization of 12.91 million, with net sales of 0.39 million and a net profit of -12.10 million over the last four quarters. The company's shareholder's funds are 8.53 million, and total assets amount to 12.28 million.

View full answer

What does BioRestorative Therapies, Inc. do?

22-Jun-2025

BioRestorative Therapies, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $0 million and a net loss of $5 million as of March 2025. The company has a market cap of $12.91 million and no dividend yield.

View full answer

Is BioRestorative Therapies, Inc. technically bullish or bearish?

20-Sep-2025

As of September 4, 2025, BioRestorative Therapies, Inc. is in a mildly bearish trend, with key indicators like daily moving averages and Bollinger Bands signaling weakness, and a 1-year return of -12.12% compared to the S&P 500's 17.14%.

View full answer

Compare BioRestorative Therapies, Inc. with Similar Stocks

Nemaura Medical, Inc.MedAvail Holdings, Inc.Talis Biomedical Corp.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 10 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-2.03

Return on Equity

-641.50%

Price to Book

4.63

Revenue and Profits:

Net Sales:

0 Million

(Quarterly Results - Jun 2025)

Net Profit:

-3 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-32.47%

6 Months

-29.25%

1 Year

-11.11%

2 Years

-80.19%

3 Years

-75.18%

4 Years

-96.71%

5 Years

30.0%

BioRestorative Therapies, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

8.30%

EBIT Growth (5y)

-186.65%

EBIT to Interest (avg)

-15.12

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.48

Sales to Capital Employed (avg)

0.05

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

8.01%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

2.20

EV to EBIT

-0.36

EV to EBITDA

-0.37

EV to Capital Employed

-1.49

EV to Sales

4.43

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-190.35%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 2 Schemes (2.02%)

Foreign Institutions

Held by 3 Foreign Institutions (0.0%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 49.06% vs -231.25% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.30",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-3.30",
          "val2": "-4.80",
          "chgp": "31.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.60",
          "val2": "-0.60",
          "chgp": "200.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.70",
          "val2": "-5.30",
          "chgp": "49.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-10,897.70%",
          "val2": "-192,301.40%",
          "chgp": "18,140.37%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 300.00% vs 0.00% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 13.46% vs 21.21% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.40",
          "val2": "0.10",
          "chgp": "300.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-11.40",
          "val2": "-15.10",
          "chgp": "24.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.80",
          "val2": "4.00",
          "chgp": "-55.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-9.00",
          "val2": "-10.40",
          "chgp": "13.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-28,815.90%",
          "val2": "-104,394.90%",
          "chgp": "7,557.90%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

0.30

0.00

Operating Profit (PBDIT) excl Other Income

-3.30

-4.80

31.25%

Interest

0.00

Exceptional Items

0.60

-0.60

200.00%

Consolidate Net Profit

-2.70

-5.30

49.06%

Operating Profit Margin (Excl OI)

-10,897.70%

-192,301.40%

18,140.37%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 49.06% vs -231.25% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

0.40

0.10

300.00%

Operating Profit (PBDIT) excl Other Income

-11.40

-15.10

24.50%

Interest

0.00

Exceptional Items

1.80

4.00

-55.00%

Consolidate Net Profit

-9.00

-10.40

13.46%

Operating Profit Margin (Excl OI)

-28,815.90%

-104,394.90%

7,557.90%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 300.00% vs 0.00% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 13.46% vs 21.21% in Dec 2023

All Annual Results

Company CV

About BioRestorative Therapies, Inc.

BioRestorative Therapies, Inc.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

BioRestorative Therapies, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is BioRestorative Therapies, Inc.?

Watch in Real-Time

What does BioRestorative Therapies, Inc. do?

Is BioRestorative Therapies, Inc. technically bullish or bearish?

Compare BioRestorative Therapies, Inc. with Similar Stocks

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Annual Results Snapshot (Consolidated) - Dec'24

About BioRestorative Therapies, Inc.

Company Coordinates